Genetically engineered Newcastle disease virus for malignant melanoma therapy.
Jun 2009 - Gene Ther.; 16(6):1476-5462 [PMID:19242529]
[Zamarin D] [Vigil A] [Kelly K] [García-Sastre A] [Fong Y]

Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses.
Apr 2009 - Mol. Ther.; 17(4):1525-0024 [PMID:19209145]
[Zamarin D] [Martínez-Sobrido L] [Kelly K] [Mansour M] [Sheng G] [Vigil A] [García-Sastre A] [Palese P] [Fong Y]